Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: Part 2. Synthesis of rigid pyrazolones
- 1 August 2009
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 17 (15), 5716-5721
- https://doi.org/10.1016/j.bmc.2009.05.058
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosisBioorganic & Medicinal Chemistry, 2008
- 1,5-Diphenylpyrrole Derivatives as Antimycobacterial Agents. Probing the Influence on Antimycobacterial Activity of Lipophilic Substituents at the Phenyl RingsJournal of Medicinal Chemistry, 2008
- Natural Products, Small Molecules, and Genetics in Tuberculosis Drug DevelopmentJournal of Medicinal Chemistry, 2008
- Antituberculosis drugs: Ten years of researchBioorganic & Medicinal Chemistry, 2007
- Ligand‐Based Virtual Screening, Parallel Solution‐Phase and Microwave‐Assisted Synthesis as Tools to Identify and Synthesize New Inhibitors of Mycobacterium tuberculosisChemMedChem, 2006
- Antimycobacterial Agents. Novel Diarylpyrrole Derivatives of BM212 Endowed with High Activity toward Mycobacterium tuberculosis and Low CytotoxicityJournal of Medicinal Chemistry, 2006
- On the tautomerism of pyrazolones: the geminal 2J[pyrazole C-4,H-3(5)] spin coupling constant as a diagnostic toolTetrahedron, 2004
- BM 212 and its derivatives as a new class of antimycobacterial active agents.Current Medicinal Chemistry, 2002
- Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 2002
- Bactericidal Activities of the Pyrrole Derivative BM212 against Multidrug-Resistant and Intramacrophagic Mycobacterium tuberculosis StrainsAntimicrobial Agents and Chemotherapy, 1998